Candriam SCA’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Candriam SCA’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-51,000	Closed	-$2.71M	–	705
2016 Q1	$2.71M	Buy	+51,000	New	+$3.76M	0.07%	279
2015 Q4	–	Sell	-45,500	Closed	-$5.36M	–	674
2015 Q3	$5.36M	Buy	+45,500	New	+$5.94M	0.13%	191
2015 Q2	–	Sell	-50,000	Closed	-$2.89M	–	695
2015 Q1	$2.89M	Sell	50,000 -70,000	-58%	-$2.97M	0.06%	341
2014 Q4	$3.87M	Buy	+120,000	New	+$3.6M	0.08%	276

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Candriam SCA's ANAC Position: Q2 2016 in Review

Candriam SCA sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 51,000 shares — an estimated $2.71M sold.

Candriam SCA first reported a position in ANAC in Q4 2014 and held it in 4 quarters. The position peaked at $5.36M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Candriam SCA reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Candriam SCA sold 51,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2.71M.
Candriam SCA first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 4 quarters.
Candriam SCA's ANACOR PHARMACEUTICALS INC COM position peaked at $5.36M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.